10.19.15
BioClinica Inc., a specialty clinical trials technology services provider, has unveiled a new eClinical CRO Partner Alliance program, accelerating adoption of industry-leading eHealth solutions by CROs. The decision to redesign the CRO partner channel comes in response to growing demand for a premier eClinical technology platform that enables CROs and sponsors to conduct studies in an efficient and accelerated manner.
“We listened to our eClinical CRO customers, sponsors and the wider community to understand business pain-points, as well as the overall experience of working with technology product providers,” said Mukhtar Ahmed, BioClinica’s eClinical business segment president. “Based on feedback from senior clinical development, outsourcing and IT executives, it was evident a completely different partnering approach and philosophy was desired.”
Mr. Ahmed added, “Among their top priorities are CRO autonomy and product self-service capability, as well as access to a wealth of knowledge and best practices. They want this within a true partnership—one with strategic business alignment, collaboration and accountability for service delivery and product quality.”
To address this need, BioClinica’s eClinical CRO Partner Alliance is flexible and built around each partner’s unique needs and business model. BioClinica director of CRO business development, Jason Attanucci, said, “Our CRO partners receive flexible licensing, preferred pricing and incentives along with service and quality assurance benefits, which ultimately help them reach sponsor customers previously inaccessible.”
Dedicated CRO relationship managers work closely with each partner to create a tailored eHealth solution offering. Partners may leverage certification and services in the BioClinica platform or individual solutions to achieve unique financial benefits in areas including:
• Randomization, trial supply management and forecasting with predictive analytics
Intelligent risk-based monitoring;
• Clinical trial management, operations and payments; and
• Electronic data capture, comprehensive data management, and clinical operations support.
“We listened to our eClinical CRO customers, sponsors and the wider community to understand business pain-points, as well as the overall experience of working with technology product providers,” said Mukhtar Ahmed, BioClinica’s eClinical business segment president. “Based on feedback from senior clinical development, outsourcing and IT executives, it was evident a completely different partnering approach and philosophy was desired.”
Mr. Ahmed added, “Among their top priorities are CRO autonomy and product self-service capability, as well as access to a wealth of knowledge and best practices. They want this within a true partnership—one with strategic business alignment, collaboration and accountability for service delivery and product quality.”
To address this need, BioClinica’s eClinical CRO Partner Alliance is flexible and built around each partner’s unique needs and business model. BioClinica director of CRO business development, Jason Attanucci, said, “Our CRO partners receive flexible licensing, preferred pricing and incentives along with service and quality assurance benefits, which ultimately help them reach sponsor customers previously inaccessible.”
Dedicated CRO relationship managers work closely with each partner to create a tailored eHealth solution offering. Partners may leverage certification and services in the BioClinica platform or individual solutions to achieve unique financial benefits in areas including:
• Randomization, trial supply management and forecasting with predictive analytics
Intelligent risk-based monitoring;
• Clinical trial management, operations and payments; and
• Electronic data capture, comprehensive data management, and clinical operations support.